This chapter explores the complexities of clinical trials involving MDMA as a treatment for PTSD, emphasizing the monitoring of suicidal tendencies among participants. Concerns regarding self-reporting pressures and the long-term effects of the therapy are discussed, alongside personal accounts of participants' experiences. The chapter underscores the need for comprehensive oversight and understanding as the debate continues on the drug's potential approval for therapeutic use.
A clinical trial for MDMA-assisted therapy showed promising results. But participants who say they suffered afterward allege their experiences aren’t reflected in the data.
This episode was reported and produced by Haleema Shah, engineered by Andrea Kristinsdottir and Rob Byers, and hosted by Sean Rameswaram. It was edited by Lissa Soep and Matt Collette, who also fact-checked. It’s the final episode in a series supported with a grant from the Ferriss–UC Berkeley Psychedelic Journalism Fellowship.
Transcript at vox.com/today-explained-podcast
Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members
Learn more about your ad choices. Visit podcastchoices.com/adchoices